| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Lyra Therapeutics, Inc. | SVP, Regulatory Affairs | Stock Option | 30,000 | 12 Feb 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LYRA | Lyra Therapeutics, Inc. | 12 Feb 2022 | 1 | $0 | 4 | SVP, Regulatory Affairs | 15 Feb 2022, 20:30 |